香港股市 已收市

Bio-Rad Laboratories, Inc. (BIO)

NYSE - Nasdaq 即時價格。貨幣為 USD。
加入追蹤清單
281.18+1.88 (+0.67%)
市場開市。 截至 01:03PM EDT。

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000
https://www.bio-rad.com

版塊Healthcare
行業Medical Devices
全職員工8,030

高階主管

名稱頭銜支付行使價出生年份
Mr. Norman D. SchwartzChairman, CEO & President1.25M19.51M1950
Dr. Andrew J. Last Ph.D.Executive VP & COO682.29k1960
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

公司管治

截至 2024年5月1日 止,Bio-Rad Laboratories, Inc. 的 ISS 管治質素評分為 10。 Pillar 分數正在審核中:9;董事會:10;股東權利:10;現金賠償:4。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。